Zomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers Acquires 100,000 Shares of Stock

Zomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers acquired 100,000 shares of Zomedica stock in a transaction dated Friday, November 17th. The shares were purchased at an average price of $0.17 per share, with a total value of $17,000.00. Following the acquisition, the director now owns 1,850,000 shares of the company’s stock, valued at $314,500. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Zomedica Stock Up 4.9 %

ZOM opened at $0.18 on Tuesday. Zomedica Corp. has a 1 year low of $0.15 and a 1 year high of $0.34. The firm has a market capitalization of $171.79 million, a P/E ratio of -5.84 and a beta of 0.98.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. FMR LLC lifted its position in shares of Zomedica by 941.6% during the 3rd quarter. FMR LLC now owns 220,496 shares of the company’s stock valued at $37,000 after acquiring an additional 199,328 shares during the period. XTX Topco Ltd acquired a new stake in Zomedica during the second quarter worth about $41,000. Two Sigma Securities LLC grew its stake in Zomedica by 719.0% during the second quarter. Two Sigma Securities LLC now owns 371,870 shares of the company’s stock worth $74,000 after buying an additional 326,467 shares in the last quarter. BlackRock Inc. increased its holdings in Zomedica by 12.3% in the 2nd quarter. BlackRock Inc. now owns 11,511,024 shares of the company’s stock valued at $2,302,000 after buying an additional 1,264,183 shares during the period. Finally, ProShare Advisors LLC lifted its holdings in shares of Zomedica by 38.4% during the 2nd quarter. ProShare Advisors LLC now owns 2,949,901 shares of the company’s stock worth $590,000 after acquiring an additional 819,163 shares during the period. 9.89% of the stock is owned by institutional investors.

About Zomedica

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform and VetGuardian, a zero-touch vital signs remote monitoring system, as well as Revo Squared imaging platform comprising diagnostic imaging products and services for use in animal health.